Operating Expenses Summary of Apex Biotechnology Corp.

Apex Biotechnology Corp.'s latest annual operating expenses in 2023 was 389.4 Million TWD , down -2.72% from previous year.
Apex Biotechnology Corp.'s latest quarterly operating expenses in 2024 Q2 was 93.53 Million TWD , up 15.1% from previous quarter.
Apex Biotechnology Corp. reported a annual operating expenses of 400.27 Million TWD in annual operating expenses 2022, up 8.17% from previous year.
Apex Biotechnology Corp. reported a annual operating expenses of 370.05 Million TWD in annual operating expenses 2021, up 5.96% from previous year.
Apex Biotechnology Corp. reported a quarterly operating expenses of 86.76 Million TWD for 2024 Q1, down -11.7% from previous quarter.
Apex Biotechnology Corp. reported a quarterly operating expenses of 98.26 Million TWD for 2023 Q4, down -1.51% from previous quarter.

Annual Operating Expenses Chart of Apex Biotechnology Corp. (2023 - 2009)

Historical Annual Operating Expenses of Apex Biotechnology Corp. (2023 - 2009)

Year	Operating Expenses	Operating Expenses Growth
2023	389.4 Million TWD	-2.72%
2022	400.27 Million TWD	8.17%
2021	370.05 Million TWD	5.96%
2020	349.25 Million TWD	-9.74%
2019	386.96 Million TWD	16.29%
2018	332.75 Million TWD	23.01%
2017	270.51 Million TWD	17.13%
2016	230.95 Million TWD	-6.25%
2015	246.34 Million TWD	4.74%
2014	235.18 Million TWD	7.17%
2013	219.45 Million TWD	6.65%
2012	205.76 Million TWD	7.41%
2011	191.57 Million TWD	6.51%
2010	179.85 Million TWD	10.35%
2009	162.98 Million TWD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	93.53 Million TWD	15.1%
2024 Q1	86.76 Million TWD	-11.7%
2023 Q4	98.26 Million TWD	-1.51%
2023 Q2	99.2 Million TWD	7.64%
2023 FY	389.4 Million TWD	-2.72%
2023 Q1	92.16 Million TWD	-14.02%
2023 Q3	99.77 Million TWD	0.57%
2022 Q3	100.43 Million TWD	0.34%
2022 FY	400.27 Million TWD	8.17%
2022 Q1	92.56 Million TWD	-8.16%
2022 Q4	107.18 Million TWD	6.72%
2022 Q2	100.09 Million TWD	8.13%
2021 FY	370.05 Million TWD	5.96%
2021 Q3	91.48 Million TWD	2.12%
2021 Q1	88.19 Million TWD	9.32%
2021 Q4	100.78 Million TWD	10.16%
2021 Q2	89.58 Million TWD	1.57%
2020 Q2	90.71 Million TWD	1.94%
2020 Q1	88.99 Million TWD	-8.92%
2020 Q4	80.68 Million TWD	-9.21%
2020 FY	349.25 Million TWD	-9.74%
2020 Q3	88.86 Million TWD	-2.05%
2019 Q3	98.68 Million TWD	-4.45%
2019 FY	386.96 Million TWD	16.29%
2019 Q1	87.29 Million TWD	8.1%
2019 Q2	103.27 Million TWD	18.3%
2019 Q4	97.71 Million TWD	-0.98%
2018 Q2	83.5 Million TWD	4.4%
2018 FY	332.75 Million TWD	23.01%
2018 Q3	88.5 Million TWD	5.98%
2018 Q1	79.98 Million TWD	-5.24%
2018 Q4	80.75 Million TWD	-8.75%
2017 Q4	84.4 Million TWD	8.84%
2017 Q1	60.89 Million TWD	8.32%
2017 Q3	77.55 Million TWD	62.71%
2017 FY	270.51 Million TWD	17.13%
2017 Q2	47.66 Million TWD	-21.73%
2016 Q4	56.21 Million TWD	1.51%
2016 FY	230.95 Million TWD	-6.25%
2016 Q1	53.67 Million TWD	-23.65%
2016 Q2	65.68 Million TWD	22.38%
2016 Q3	55.37 Million TWD	-15.69%
2015 Q3	58.77 Million TWD	-1.22%
2015 FY	246.34 Million TWD	4.74%
2015 Q1	57.76 Million TWD	-17.64%
2015 Q2	59.5 Million TWD	3.0%
2015 Q4	70.29 Million TWD	19.61%
2014 Q1	54.1 Million TWD	-6.37%
2014 Q4	70.14 Million TWD	21.61%
2014 Q3	57.67 Million TWD	8.28%
2014 Q2	53.26 Million TWD	-1.54%
2014 FY	235.18 Million TWD	7.17%
2013 Q3	53 Million TWD	-5.44%
2013 Q4	57.78 Million TWD	9.0%
2013 FY	219.45 Million TWD	6.65%
2013 Q1	52.61 Million TWD	-0.54%
2013 Q2	56.05 Million TWD	6.54%
2012 Q2	52.25 Million TWD	4.17%
2012 FY	205.76 Million TWD	7.41%
2012 Q3	49.76 Million TWD	-4.77%
2012 Q1	50.16 Million TWD	-5.61%
2012 Q4	52.89 Million TWD	6.3%
2011 Q4	53.14 Million TWD	-5.13%
2011 Q1	39.08 Million TWD	-11.75%
2011 Q3	56.02 Million TWD	29.32%
2011 FY	191.57 Million TWD	6.51%
2011 Q2	43.31 Million TWD	10.83%
2010 Q2	47.04 Million TWD	11.19%
2010 Q4	44.29 Million TWD	-4.15%
2010 Q1	42.3 Million TWD	0.0%
2010 FY	179.85 Million TWD	10.35%
2010 Q3	46.2 Million TWD	-1.77%
2009 FY	162.98 Million TWD	0.0%

Peer Operating Expenses Comparison of Apex Biotechnology Corp.

Name	Operating Expenses	Operating Expenses Difference
Sinphar Pharmaceutical Co.,Ltd.	807.86 Million TWD	51.799%
Panion & Bf Biotech Inc.	817.56 Million TWD	52.371%
Chunghwa Chemical Synthesis & Biotech Co., Ltd.	437.58 Million TWD	11.011%
GenMont Biotech Incorporation	204.2 Million TWD	-90.692%
Abnova (Taiwan) Corporation	126.72 Million TWD	-207.289%
Adimmune Corporation	1.13 Billion TWD	65.652%
Tanvex BioPharma, Inc.	2.16 Billion TWD	81.976%
Polaris Group	-3.06 Million TWD	12804.731%
Energenesis Biomedical CO.,LTD.	267.06 Million TWD	-45.808%
UnicoCell Biomed Co., Ltd.	17.89 Million TWD	-2075.784%
PELL Bio-Med Technology Co. Ltd.	385.1 Million TWD	-1.115%

Global Stocks Search

Apex Biotechnology Corp. (1733.TW)

Operating Expenses Summary of Apex Biotechnology Corp.

Annual Operating Expenses Chart of Apex Biotechnology Corp. (2023 - 2009)

Historical Annual Operating Expenses of Apex Biotechnology Corp. (2023 - 2009)

Peer Operating Expenses Comparison of Apex Biotechnology Corp.